| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Valerie Mizrahi | Q22006961 |
| Digby F Warner | Q78493097 | ||
| P2860 | cites work | Mycobacterium bovis BCG recA deletion mutant shows increased susceptibility to DNA-damaging agents but wild-type survival in a mouse infection model. | Q34007536 |
| Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation | Q34009146 | ||
| Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas | Q34009894 | ||
| Fitness cost of chromosomal drug resistance-conferring mutations | Q34107494 | ||
| Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates | Q34123800 | ||
| Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. | Q34131132 | ||
| Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria | Q34146531 | ||
| DNA metabolism in mycobacterium tuberculosis: implications for drug resistance and strain variability | Q34172124 | ||
| In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions. | Q34184123 | ||
| DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis | Q34191816 | ||
| Second-order selection in bacterial evolution: selection acting on mutation and recombination rates in the course of adaptation | Q34203956 | ||
| Toxin-antitoxin loci as stress-response-elements: ChpAK/MazF and ChpBK cleave translated RNAs and are counteracted by tmRNA. | Q34230226 | ||
| Stable association between strains of Mycobacterium tuberculosis and their human host populations | Q34308443 | ||
| Structural basis for transcription regulation by alarmone ppGpp. | Q34316432 | ||
| Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains | Q34318969 | ||
| Mycobacterium bovis BCG response regulator essential for hypoxic dormancy | Q34321220 | ||
| Recombination-deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages | Q34355873 | ||
| The rise and fall of mutator bacteria. | Q34392588 | ||
| The PIN-domain toxin-antitoxin array in mycobacteria | Q34430557 | ||
| Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence | Q34467579 | ||
| Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? | Q34479624 | ||
| Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family | Q34502921 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid | Q34542604 | ||
| Regulation of ribosomal RNA synthesis in E. coli: effects of the global regulator guanosine tetraphosphate (ppGpp). | Q34586742 | ||
| Reactive nitrogen and oxygen intermediates and bacterial defenses: unusual adaptations in Mycobacterium tuberculosis | Q34611241 | ||
| Genome-wide analysis of synonymous single nucleotide polymorphisms in Mycobacterium tuberculosis complex organisms: resolution of genetic relationships among closely related microbial strains. | Q34616646 | ||
| The fate of microbial mutators | Q34623647 | ||
| Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review | Q34762099 | ||
| Mycobacterium and the coat of many lipids | Q34766315 | ||
| Roles of YqjH and YqjW, homologs of the Escherichia coli UmuC/DinB or Y superfamily of DNA polymerases, in stationary-phase mutagenesis and UV-induced mutagenesis of Bacillus subtilis | Q34810207 | ||
| Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity | Q34945420 | ||
| Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate | Q34975227 | ||
| Massive gene decay in the leprosy bacillus | Q22122381 | ||
| Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence | Q22122411 | ||
| The Envelope of Mycobacteria | Q22241995 | ||
| Mycobacterium tuberculosis in the Extracellular Compartment: an Underestimated Adversary | Q22242240 | ||
| SOS-induced DNA polymerases enhance long-term survival and evolutionary fitness | Q24530758 | ||
| A new evolutionary scenario for the Mycobacterium tuberculosis complex | Q24531514 | ||
| Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective | Q24535810 | ||
| Definition of the mycobacterial SOS box and use to identify LexA-regulated genes in Mycobacterium tuberculosis | Q24538994 | ||
| Bacterial persistence: a model of survival in changing environments | Q24544968 | ||
| Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials | Q24548874 | ||
| Riddle of biofilm resistance | Q24550611 | ||
| RelE, a global inhibitor of translation, is activated during nutritional stress | Q24555067 | ||
| Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes | Q24556626 | ||
| Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis | Q24610295 | ||
| Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro | Q24618059 | ||
| Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis | Q24624866 | ||
| Unique type of plasmid maintenance function: postsegregational killing of plasmid-free cells | Q24630262 | ||
| Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens | Q24630289 | ||
| Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages | Q24644376 | ||
| Regulation of sigma factor competition by the alarmone ppGpp | Q24675316 | ||
| hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis | Q24685235 | ||
| Genes required for mycobacterial growth defined by high density mutagenesis | Q27976512 | ||
| Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update | Q28143206 | ||
| The curious characteristics of pyrazinamide: a review | Q28191713 | ||
| Stress-directed adaptive mutations and evolution | Q28257836 | ||
| Treatment of multidrug-resistant tuberculosis | Q28261482 | ||
| The Garrod Lecture. Understanding the chemotherapy of tuberculosis--current problems | Q28320729 | ||
| The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages | Q28343891 | ||
| Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro | Q28369434 | ||
| Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis | Q28378761 | ||
| Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis | Q28378868 | ||
| An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence | Q28378895 | ||
| Ancestral antibiotic resistance in Mycobacterium tuberculosis | Q28486382 | ||
| Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis | Q28486418 | ||
| The stringent response of Mycobacterium tuberculosis is required for long-term survival | Q28486427 | ||
| Characterization of mRNA interferases from Mycobacterium tuberculosis | Q28486506 | ||
| mmr, a Mycobacterium tuberculosis gene conferring resistance to small cationic dyes and inhibitors. | Q28486520 | ||
| Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis | Q28486521 | ||
| Peroxynitrite reductase activity of bacterial peroxiredoxins | Q28486648 | ||
| Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis | Q28486661 | ||
| Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates | Q28486763 | ||
| The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice | Q28486838 | ||
| Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxide | Q28486863 | ||
| DNA alkylation damage as a sensor of nitrosative stress in Mycobacterium tuberculosis | Q28486985 | ||
| Response of Mycobacterium tuberculosis to reactive oxygen and nitrogen intermediates | Q28486997 | ||
| Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton alpha-crystallin homolog by exposure to nitric oxide donors | Q28487034 | ||
| Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst | Q43597705 | ||
| Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction | Q43601503 | ||
| Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs | Q43891804 | ||
| ParE toxin encoded by the broad-host-range plasmid RK2 is an inhibitor of Escherichia coli gyrase | Q43993322 | ||
| Gene expression profiling of Escherichia coli growth transitions: an expanded stringent response model | Q44067985 | ||
| The role of the alarmone (p)ppGpp in sigma N competition for core RNA polymerase. | Q44209223 | ||
| Patients with active tuberculosis often have different strains in the same sputum specimen | Q44209917 | ||
| Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days | Q44273153 | ||
| Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics | Q44352783 | ||
| Importance of uracil DNA glycosylase in Pseudomonas aeruginosa and Mycobacterium smegmatis, G+C-rich bacteria, in mutation prevention, tolerance to acidified nitrite, and endurance in mouse macrophages | Q44392751 | ||
| Stress-induced mutagenesis in bacteria | Q44459277 | ||
| Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium | Q44666207 | ||
| Mycobacterium tuberculosis resides in nonacidified vacuoles in endocytically competent alveolar macrophages from patients with tuberculosis and HIV infection | Q44807499 | ||
| The Mycobacterium tuberculosis dosRS two-component system is induced by multiple stresses. | Q44944731 | ||
| Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis | Q44991741 | ||
| SOS response induction by beta-lactams and bacterial defense against antibiotic lethality | Q45016731 | ||
| Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. | Q45029777 | ||
| Export of recombinant Mycobacterium tuberculosis superoxide dismutase is dependent upon both information in the protein and mycobacterial export machinery. A model for studying export of leaderless proteins by pathogenic mycobacteria. | Q46022626 | ||
| Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance | Q46221499 | ||
| Working alliance for TB drug development, Cape Town, South Africa, February 8th, 2000. | Q46807723 | ||
| The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action | Q47215316 | ||
| Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy | Q47966511 | ||
| Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. | Q48063219 | ||
| Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid | Q48070782 | ||
| Models for the spread of resistant pathogens. | Q52028589 | ||
| Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance. | Q52246365 | ||
| Permeability of the cell wall of Mycobacterium smegmatis. | Q52370733 | ||
| Biphasic kinetics of bacterial killing by quinolones. | Q52454358 | ||
| Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. | Q53987303 | ||
| Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment. | Q54034169 | ||
| Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. | Q54042955 | ||
| Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. | Q54073909 | ||
| Management of MDR-TB in resource-poor countries. | Q54081249 | ||
| DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence? | Q54120570 | ||
| Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. | Q54135396 | ||
| RelE toxins from bacteria and Archaea cleave mRNAs on translating ribosomes, which are rescued by tmRNA. | Q54524054 | ||
| Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis | Q28487067 | ||
| Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes | Q28487095 | ||
| The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol | Q28487116 | ||
| Mycobacterium tuberculosis genes induced during infection of human macrophages | Q28487178 | ||
| Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis | Q28487251 | ||
| Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis | Q28487294 | ||
| Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates | Q28487325 | ||
| Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment | Q28487339 | ||
| Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling | Q28487482 | ||
| Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin | Q28487527 | ||
| The Mycobacterium tuberculosis IdeR is a dual functional regulator that controls transcription of genes involved in iron acquisition, iron storage and survival in macrophages | Q28487578 | ||
| Mechanism of nonhomologous end-joining in mycobacteria: a low-fidelity repair system driven by Ku, ligase D and ligase C | Q28501841 | ||
| Error-prone DNA polymerases: novel structures and the benefits of infidelity | Q28646690 | ||
| Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria | Q28769089 | ||
| Genetic requirements for mycobacterial survival during infection | Q29547599 | ||
| Immunology of tuberculosis | Q29614370 | ||
| The Y-family of DNA polymerases | Q29615308 | ||
| Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program | Q29615311 | ||
| Nonreplicating persistence of mycobacterium tuberculosis | Q29615312 | ||
| Nitric oxide and macrophage function | Q29615327 | ||
| Prokaryotic toxin-antitoxin stress response loci | Q29615335 | ||
| The growing burden of tuberculosis: global trends and interactions with the HIV epidemic | Q29616520 | ||
| Bacterial persistence as a phenotypic switch | Q29618111 | ||
| Nitric oxide as a secretory product of mammalian cells | Q29620372 | ||
| Identification of nitric oxide synthase as a protective locus against tuberculosis | Q29620411 | ||
| A DNA repair system specific for thermophilic Archaea and bacteria predicted by genomic context analysis | Q30669971 | ||
| noxR3, a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and oxidative stress. | Q30720627 | ||
| The RD1 virulence locus of Mycobacterium tuberculosis regulates DNA transfer in Mycobacterium smegmatis | Q31106009 | ||
| Mechanism of regulation of transcription initiation by ppGpp. I. Effects of ppGpp on transcription initiation in vivo and in vitro | Q31852675 | ||
| The chemistry of DNA damage from nitric oxide and peroxynitrite | Q33538097 | ||
| Replication dynamics of Mycobacterium tuberculosis in chronically infected mice | Q33557117 | ||
| Mycobacterium tuberculosis phagosome | Q33597697 | ||
| Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century | Q33697814 | ||
| Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients | Q33716960 | ||
| Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations | Q33722011 | ||
| The biological cost of antibiotic resistance | Q33745219 | ||
| Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. | Q33757130 | ||
| Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus". | Q33791822 | ||
| Microbial glycolipids: possible virulence factors that scavenge oxygen radicals | Q33848491 | ||
| The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions | Q33890335 | ||
| Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori | Q33952076 | ||
| SOS mutator DNA polymerase IV functions in adaptive mutation and not adaptive amplification | Q33953638 | ||
| The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. | Q33960385 | ||
| Evidence for the adaptive evolution of mutation rates | Q33967135 | ||
| MazF Cleaves Cellular mRNAs Specifically at ACA to Block Protein Synthesis in Escherichia coli | Q33973437 | ||
| Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA | Q33977235 | ||
| Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. | Q33977319 | ||
| Drug tolerance in Mycobacterium tuberculosis | Q33977977 | ||
| A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. | Q33987554 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. | Q54743303 | ||
| Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally | Q56461993 | ||
| Costs and Benefits of High Mutation Rates: Adaptive Evolution of Bacteria in the Mouse Gut | Q56944626 | ||
| Highly Variable Mutation Rates in Commensal and Pathogenic Escherichia coli | Q56944671 | ||
| Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema | Q58643378 | ||
| Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis | Q59486017 | ||
| The Bacterial Toxin RelE Displays Codon-Specific Cleavage of mRNAs in the Ribosomal A Site | Q59580677 | ||
| The Role of Phagocytic Respiratory Burst in Host Defense Against Mycobacterium tuberculosis | Q59699865 | ||
| Induction of the SOS response by new 4-quinolones | Q68220052 | ||
| The intrinsic resistance of Escherichia coli to various antimicrobial agents requires ppGpp and sigma s | Q73424151 | ||
| The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis | Q73821527 | ||
| Comparative roles of free fatty acids with reactive nitrogen intermediates and reactive oxygen intermediates in expression of the anti-microbial activity of macrophages against Mycobacterium tuberculosis | Q74129598 | ||
| A tetrameric porin limits the cell wall permeability of Mycobacterium smegmatis | Q74491267 | ||
| Enumeration of viable tubercle bacilli from the organs of nonimmunized and immunized mice | Q74631964 | ||
| Conjugal transfer of chromosomal DNA in Mycobacterium smegmatis | Q74667585 | ||
| The in vitro action of antituberculous agents against multiplying and non-multiplying microbial cells | Q74726087 | ||
| Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice | Q77344847 | ||
| Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection | Q77537543 | ||
| Some comparative aspects of rifampicin and isoniazid | Q93782415 | ||
| DNA deaminating ability and genotoxicity of nitric oxide and its progenitors | Q34983829 | ||
| Comparing genomes within the species Mycobacterium tuberculosis | Q35033207 | ||
| The effect of drug resistance on the fitness of Mycobacterium tuberculosis | Q35035354 | ||
| Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling | Q35086139 | ||
| Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. | Q35139043 | ||
| The secret lives of the pathogenic mycobacteria | Q35550615 | ||
| Persistence of antibiotic resistant bacteria | Q35565589 | ||
| Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes | Q35604706 | ||
| M. tuberculosis persistence, latency, and drug tolerance | Q35605917 | ||
| Efflux-mediated drug resistance in bacteria | Q35626332 | ||
| A tale of two lipids: Mycobacterium tuberculosis phagosome maturation arrest. | Q35703065 | ||
| Identification of macrophage and stress-induced proteins of Mycobacterium tuberculosis | Q35750452 | ||
| Evolutionary significance of stress-induced mutagenesis in bacteria | Q35785631 | ||
| Mycobacterium tuberculosis gene expression during environmental conditions associated with latency | Q35810865 | ||
| Mathematical model for comparison of time-killing curves | Q35817983 | ||
| Tuberculosis - metabolism and respiration in the absence of growth | Q35988766 | ||
| Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts. | Q36153946 | ||
| Mycobacterium tuberculosis and the host response | Q36154094 | ||
| Stress responses in mycobacteria | Q36203677 | ||
| The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug | Q36263124 | ||
| Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy | Q36263128 | ||
| Effects of the ccd function of the F plasmid on bacterial growth | Q36365048 | ||
| Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis | Q36366661 | ||
| A novel antioxidant gene from Mycobacterium tuberculosis | Q36380939 | ||
| Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice | Q36402431 | ||
| Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization | Q36558993 | ||
| Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump | Q36574542 | ||
| Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness | Q37120860 | ||
| Isoniazid resistance and the future of drug-resistant tuberculosis | Q37120865 | ||
| The temporal expression profile of Mycobacterium tuberculosis infection in mice. | Q37358252 | ||
| Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains | Q37415303 | ||
| Transcription regulation by the Mycobacterium tuberculosis alternative sigma factor SigD and its role in virulence | Q37513666 | ||
| Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli | Q37663571 | ||
| The Influence of Adverse Conditions upon the Respiratory Metabolism and Growth of Human Tubercle Bacilli | Q37678699 | ||
| The frequency of mutators in populations of Escherichia coli | Q38304923 | ||
| Stable incidence rates of tuberculosis (TB) among human immunodeficiency virus (HIV)-negative South African gold miners during a decade of epidemic HIV-associated TB. | Q38482081 | ||
| Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms? | Q38730565 | ||
| Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners | Q38953084 | ||
| A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms | Q39473121 | ||
| Escherichia coli cells exposed to streptomycin display a mutator phenotype | Q39494167 | ||
| Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide | Q39501282 | ||
| Mapping of Mycobacterium tuberculosis katG promoters and their differential expression in infected macrophages. | Q39504015 | ||
| Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog. | Q39564571 | ||
| High frequency of mutator strains among human uropathogenic Escherichia coli isolates. | Q39694657 | ||
| Antibiotic tolerance among clinical isolates of bacteria | Q39750871 | ||
| Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. | Q39782912 | ||
| Antimicrobial agent resistance in mycobacteria: molecular genetic insights. | Q39820619 | ||
| Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice | Q39821342 | ||
| Method for staining both acid-fast and chromophobic tubercle bacilli with carbolfuschsin | Q40245864 | ||
| Dormancy ofMycobacterium tuberculosis and latency of disease | Q40494910 | ||
| A recA deletion mutant of Mycobacterium bovis BCG confers protection equivalent to that of wild-type BCG but shows increased genetic stability. | Q40560479 | ||
| Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis | Q40572948 | ||
| Mycobacterial cell wall: structure and role in natural resistance to antibiotics | Q40648841 | ||
| Prevention of drug access to bacterial targets: permeability barriers and active efflux | Q40737334 | ||
| Involvement of error-prone DNA polymerase IV in stationary-phase mutagenesis in Pseudomonas putida | Q40763644 | ||
| Immunopathogenesis of pulmonary tuberculosis | Q40868525 | ||
| Studies on the effect of starvation on mycobacteria | Q40879525 | ||
| Selective compartments for resistant microorganisms in antibiotic gradients | Q40885917 | ||
| Nitric oxide-induced mutations in the HPRT gene of human lymphoblastoid TK6 cells and in Salmonella typhimurium | Q40897884 | ||
| Mobile genetic elements in mycobacteria | Q40963303 | ||
| Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis | Q40968122 | ||
| Drug sensitivity and environmental adaptation of mycobacterial cell wall components. | Q41129978 | ||
| Role for nucleotide excision repair in virulence of Mycobacterium tuberculosis | Q41946149 | ||
| Chronic tuberculous empyema with bronchopleural fistula resulting in treatment failure and progressive drug resistance | Q42102509 | ||
| The early bactericidal activity of drugs in patients with pulmonary tuberculosis | Q42257164 | ||
| Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis | Q42452904 | ||
| In vitro activities of mitomycin C against growing and hypoxic dormant tubercle bacilli. | Q42730639 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| tuberculosis | Q12204 | ||
| P304 | page(s) | 558-570 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Clinical Microbiology Reviews | Q5133777 |
| P1476 | title | Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy | |
| P478 | volume | 19 |
| Q37023216 | A Flow Cytometry Method for Rapidly Assessing Mycobacterium tuberculosis Responses to Antibiotics with Different Modes of Action |
| Q37691642 | A TetR family transcriptional factor directly regulates the expression of a 3-methyladenine DNA glycosylase and physically interacts with the enzyme to stimulate its base excision activity in Mycobacterium bovis BCG |
| Q30371769 | A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis. |
| Q37426997 | A replication clock for Mycobacterium tuberculosis |
| Q33716417 | Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria |
| Q37713046 | Antimicrobial treatment improves mycobacterial survival in nonpermissive growth conditions |
| Q28539383 | Bactericidal activity of an imidazo[1, 2-a]pyridine using a mouse M. tuberculosis infection model |
| Q64114700 | Competing evolutionary paths in growing populations with applications to multidrug resistance |
| Q91839117 | Comprehensive analysis of protein acetyltransferases of human pathogen Mycobacterium tuberculosis |
| Q21092447 | Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution |
| Q37455209 | DNA repair in Mycobacterium tuberculosis revisited |
| Q37762580 | DNA repair systems and the pathogenesis of Mycobacterium tuberculosis: varying activities at different stages of infection |
| Q34532687 | Different transcriptional profiles of RAW264.7 infected with Mycobacterium tuberculosis H37Rv and BCG identified via deep sequencing |
| Q91738986 | Digital Image Analysis of Heterogeneous Tuberculosis Pulmonary Pathology in Non-Clinical Animal Models using Deep Convolutional Neural Networks |
| Q33373239 | Distinct specificities of Mycobacterium tuberculosis and mammalian proteasomes for N-acetyl tripeptide substrates |
| Q35051649 | Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism |
| Q40463792 | Early diagnosis and effective treatment regimens are the keys to tackle antimicrobial resistance in tuberculosis (TB): A report from Euroscicon's international TB Summit 2016. |
| Q39632553 | Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol |
| Q34411513 | Either non-homologous ends joining or homologous recombination is required to repair double-strand breaks in the genome of macrophage-internalized Mycobacterium tuberculosis |
| Q36132703 | Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals. |
| Q28486379 | Essential roles for imuA'- and imuB-encoded accessory factors in DnaE2-dependent mutagenesis in Mycobacterium tuberculosis |
| Q46085410 | Evidence for the role of Mycobacterium tuberculosis RecG helicase in DNA repair and recombination |
| Q39769328 | Examining the basis of isoniazid tolerance in nonreplicating Mycobacterium tuberculosis using transcriptional profiling. |
| Q37291363 | Extensively drug-resistant tuberculosis: new strains, new challenges |
| Q40601719 | Global analysis of the Staphylococcus aureus response to mupirocin |
| Q92283284 | Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery |
| Q44248755 | Homology modeling, molecular docking and DNA binding studies of nucleotide excision repair UvrC protein from M. tuberculosis. |
| Q50292411 | Hydroperoxyl enters the bacterium |
| Q46055104 | Identification of Fitness Determinants during Energy-Limited Growth Arrest in Pseudomonas aeruginosa |
| Q33291875 | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections |
| Q34881104 | Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model |
| Q36863134 | Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo. |
| Q35744854 | In-Vivo Gene Signatures of Mycobacterium tuberculosis in C3HeB/FeJ Mice |
| Q28487083 | Induced ectopic expression of HigB toxin in Mycobacterium tuberculosis results in growth inhibition, reduced abundance of a subset of mRNAs and cleavage of tmRNA |
| Q38827594 | Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India |
| Q37735417 | MenA is a promising drug target for developing novel lead molecules to combat Mycobacterium tuberculosis |
| Q30398195 | Metabolic Perspectives on Persistence |
| Q40203815 | Metabolic anticipation in Mycobacterium tuberculosis |
| Q37885402 | Metabolic regulation of antibiotic resistance. |
| Q40175360 | MiR-20b inhibits mycobacterium tuberculosis induced inflammation in the lung of mice through targeting NLRP3. |
| Q41907932 | Molecular modeling and in silico characterization of Mycobacterium tuberculosis TlyA: possible misannotation of this tubercle bacilli-hemolysin |
| Q36782015 | Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis |
| Q36524017 | Mycobacterium tuberculosis RecG binds and unwinds model DNA substrates with a preference for Holliday junctions |
| Q38297065 | Mycobacterium tuberculosis RecG protein but not RuvAB or RecA protein is efficient at remodeling the stalled replication forks: implications for multiple mechanisms of replication restart in mycobacteria |
| Q47589435 | Mycobacterium tuberculosis UvrB forms dimers in solution and interacts with UvrA in the absence of ligands. |
| Q28728356 | Mycolic acids as diagnostic markers for tuberculosis case detection in humans and drug efficacy in mice |
| Q38088794 | New tuberculosis drug development: targeting the shikimate pathway |
| Q39540019 | Peptides derived from Mycobacterium tuberculosis Rv2301 protein are involved in invasion to human epithelial cells and macrophages. |
| Q93132929 | Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance |
| Q37078271 | Problems in diagnosis and treatment of tuberculosis infection |
| Q33769195 | Role of the DinB homologs Rv1537 and Rv3056 in Mycobacterium tuberculosis |
| Q34907035 | Secreted acid phosphatase (SapM) of Mycobacterium tuberculosis is indispensable for arresting phagosomal maturation and growth of the pathogen in guinea pig tissues |
| Q39038658 | Selective killing of nonreplicating mycobacteria |
| Q28477566 | Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy |
| Q35865490 | Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages |
| Q45029263 | Study of interactions between Mycobacterium tuberculosis proteins: SigK and anti-SigK |
| Q58606136 | Synthesis and in vitro characterization of trehalose-based inhibitors of mycobacterial trehalose 6-phosphate phosphatases |
| Q37283561 | The DosR regulon of M. tuberculosis and antibacterial tolerance |
| Q39035790 | The involvement of NADPH oxidase-mediated ROS in cytokine secretion from macrophages induced by Mycobacterium tuberculosis ESAT-6. |
| Q79888520 | The survival kit of Mycobacterium tuberculosis |
| Q33648717 | The three RelE homologs of Mycobacterium tuberculosis have individual, drug-specific effects on bacterial antibiotic tolerance |
| Q37365225 | The uracil DNA glycosylase UdgB of Mycobacterium smegmatis protects the organism from the mutagenic effects of cytosine and adenine deamination |
| Q102075516 | Transcriptional regulator-induced phenotype screen reveals drug potentiators in Mycobacterium tuberculosis |
| Q27658975 | Triazaspirodimethoxybenzoyls as Selective Inhibitors of Mycobacterial Lipoamide Dehydrogenase, |
| Q37126922 | Tuberculosis genes expressed during persistence and reactivation in the resistant rabbit model |
| Q28478890 | Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum |
| Q33955336 | VapC toxins from Mycobacterium tuberculosis are ribonucleases that differentially inhibit growth and are neutralized by cognate VapB antitoxins |
| Q42139545 | Viability of stressed Mycobacterium tuberculosis and association with multidrug resistance. |
| Q38160534 | Vitamin B(12) metabolism in Mycobacterium tuberculosis |
| Q33280142 | Why is long-term therapy required to cure tuberculosis? |
Search more.